Bridgeway Capital Management’s Mesa Laboratories MLAB Stock Holding History

Bridgeway Capital Management’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	–	Sell	-10,030	Closed	-$892K	–	1494
2015 Q2	$892K	Hold	10,030	–	–	0.02%	838
2015 Q1	$724K	Hold	10,030	–	–	0.02%	930
2014 Q4	$775K	Sell	10,030 -50	-0.5%	-$3.66K	0.02%	872
2014 Q3	$582K	Hold	10,080	–	–	0.01%	1005
2014 Q2	$846K	Hold	10,080	–	–	0.02%	844
2014 Q1	$910K	Buy	10,080 +50	+0.5%	+$4.25K	0.03%	798
2013 Q4	$788K	Hold	10,030	–	–	0.02%	840
2013 Q3	$678K	Hold	10,030	–	–	0.02%	884
2013 Q2	$543K	Buy	+10,030	New	+$521K	0.02%	904

Other funds holding MLAB

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NTCM

Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Bridgeway Capital Management's MLAB Position: Q3 2015 in Review

Bridgeway Capital Management sold out of Mesa Laboratories (MLAB) in Q3 2015, closing a stake of 10,030 shares — an estimated $892K sold.

Bridgeway Capital Management first reported a position in MLAB in Q2 2013 and held it in 9 quarters. The position peaked at $910K in Q1 2014. 65 funds tracked by Wall St. Rank hold MLAB as of Q3 2015.

Bridgeway Capital Management reported no remaining Mesa Laboratories position as of Q3 2015 after selling out during the quarter.
Bridgeway Capital Management sold 10,030 Mesa Laboratories shares in Q3 2015, an estimated $892K.
Bridgeway Capital Management first reported a position in Mesa Laboratories in Q2 2013 and held it in 9 quarters.
Bridgeway Capital Management's Mesa Laboratories position peaked at $910K in Q1 2014.
65 funds tracked by Wall St. Rank held Mesa Laboratories as of Q3 2015.

Based on Bridgeway Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.